Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand.
Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand.
复制标题
DOI：
10.1371/journal.pone.0119011
复制
发表时间：
2015
期刊：
影响因子：
3.7
通讯作者：
Buetow SA
中科院分区：
文献类型：
--
作者：
Gauld NJ;Kelly FS;Emmerton LM;Buetow SA
尽管新西兰的卫生系统和跨塔斯曼协调药物时间表有相似之处，但新西兰在将处方药“转换”（重新分类）为非处方药方面比澳大利亚更为积极。确定并比较新西兰和澳大利亚的转换推动因素和障碍。我们对新西兰和澳大利亚的主要参与者以及以前在澳大利亚的国际参与者进行了27次深入的个人访谈，并分析了考虑交换机的会议记录（2000-2013）。对这两组数据的分析需要采用启发式定性方法，该方法涵盖了首席研究员的知识和经验。确定的关键主题是澳大利亚的保守主义和政治影响，以及新西兰的开放态度，积极主动和灵活性。只有药剂师的药物时间表和个人持有进步的态度，提出了促进转换在这两个国家。与澳大利亚不同，一家药店零售集团在新西兰推动了许多开关（“第三方开关”）。这两个国家转换的障碍包括市场规模小、处方药的资金和看医生的费用以及缺乏市场排他性。在澳大利亚，据报告，仅限药剂师使用的药品的广告限制阻碍了制药业提交转换申请。对药房业绩的看法可能有助于或阻碍转换。委员会和监管机构对转换的开放性以及对药房的信心似乎影响了消费者对药物的获取。澳大利亚的药剂师专用药物时间表以及新西兰第三方转换的兴起和转换的灵活性可以在其他地方考虑，以实现转换。
Despite similarities in health systems and Trans-Tasman Harmonization of medicines scheduling, New Zealand is more active than Australia in ‘switching’ (reclassifying) medicines from prescription to non-prescription. To identify and compare enablers and barriers to switch in New Zealand and Australia. We conducted and analyzed 27 in-depth personal interviews with key participants in NZ and Australia and international participants previously located in Australia, and analyzed records of meetings considering switches (2000–2013). Analysis of both sets of data entailed a heuristic qualitative approach that embraced the lead researcher’s knowledge and experience. The key themes identified were conservatism and political influences in Australia, and an open attitude, proactivity and flexibility in NZ. Pharmacist-only medicine schedules and individuals holding a progressive attitude were proposed to facilitate switch in both countries. A pharmacy retail group drove many switches in NZ (‘third-party switch’), unlike Australia. Barriers to switch in both countries included small market sizes, funding of prescription medicines and cost of doctor visits, and lack of market exclusivity. In Australia, advertising limitations for pharmacist-only medicines reportedly discouraged industry from submitting switch applications. Perceptions of pharmacy performance could help or hinder switches. Committee and regulator openness to switch, and confidence in pharmacy appear to influence consumer access to medicines. The pharmacist-only medicine schedule in Australasia and the rise of third-party switch and flexibility in switch in NZ could be considered elsewhere to enable switch.
登录
查看更多内容
影响因子：
2.4
作者：
Endacott, Ruth;Sheaff, Rod;Woodward, Valerie
通讯作者：
Woodward, Valerie
影响因子：
4.2
作者：
Cohen, Joshua
通讯作者：
Cohen, Joshua
DOI：
10.1081/crp-120018736
发表时间：
2003-01-01
期刊：
CLINICAL RESEARCH AND REGULATORY AFFAIRS
影响因子：
--
作者：
Achanta, AS;Temkin, CW;Rhodes, CT
通讯作者：
Rhodes, CT
影响因子：
8.5
作者：
DEMB, A;NEUBAUER, FF
通讯作者：
NEUBAUER, FF
影响因子：
5.2
作者：
Gauld, Natalie;Kelly, Fiona;Shaw, John
通讯作者：
Shaw, John